Merck 2017 forecast reassuring; full-speed ahead with Keytruda
Go back to Merck 2017 forecast reassuring; full-speed ahead with Keytruda| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 56.90 +56.89 (568,900.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.01 | 52 Week High | $77.12 | |||
| Open | $0.01 | 52 Week Low | $49.03 | |||
| Day High | $57.41 | P/E | 36.95 | |||
| Day Low | $55.74 | EPS | $1.54 | |||
| Volume | 8,899,759 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 120.76 +1.67 (1.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $119.09 | 52 Week High | $65.46 | |||
| Open | $120.04 | 52 Week Low | $47.97 | |||
| Day High | $122.71 | P/E | 82.15 | |||
| Day Low | $119.95 | EPS | $1.47 | |||
| Volume | 13,179,268 | |||||
